An Integrated Quantitative Proteomics Workflow for Cancer Biomarker Discovery and Validation in Plasma
Blood plasma is one of the most widely used samples for cancer biomarker discovery research as well as clinical investigations for diagnostic and therapeutic purposes. However, the plasma proteome is extremely complex due to its wide dynamic range of protein concentrations and the presence of high-a...
Main Authors: | Vipin Kumar, Sandipan Ray, Saicharan Ghantasala, Sanjeeva Srivastava |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.543997/full |
Similar Items
-
Quantitative proteomics analysis of differentially expressed proteins induced by astragaloside IV in cervical cancer cell invasion
by: Chenglai Xia, et al.
Published: (2020-03-01) -
Quantification of Cardiovascular Disease Biomarkers in Human Platelets by Targeted Mass Spectrometry
by: Sebastian Malchow, et al.
Published: (2017-11-01) -
TMT and PRM Based Quantitative Proteomics to Explore the Protective Role and Mechanism of Iristectorin B in Stroke
by: Meizhu Zheng, et al.
Published: (2023-10-01) -
Tandem mass tag-based quantitative proteomics analyses of a chicken-original virulent and its attenuated Histomonas meleagridis strain in China
by: Qiao-Guang Chen, et al.
Published: (2023-03-01) -
Discovery and validation of novel protein markers in mucosa of portal hypertensive gastropathy
by: Ying Zhu, et al.
Published: (2021-05-01)